-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
First Immunotherapy Approved for Breast Cancer
Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
-
Treating Cancer Based on Its Genetics, Not Its Location
Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
Previous |
Cancer Talk
Aggressive Approach to Very Advanced Cancer Does Not Extend Survival
Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
Making Cancer a Family AffairInstead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin